If this trial is successful, we may not need to worry about...

First 2667 Last

Share
Profile

Follow
arjay

3,705 Posts.

827

04/09/23

22:05

Post #: 69728741
Share

Originally posted by Atomboi ↑

It is interesting to think if the trial is successful (matching or beating the same results of previous) - we will be able to receive a voucher valued at anywhere between $100-300m.

We will have the option to sell the voucher to fund the next steps or part of the next steps alone by selling it OR speed up the approval by half a year.

What is the Pediatric Priority Review Voucher (pPRV)?
•PRV system designed to incentivise private sector to develop new medicines for rare and underserved diseases
•pPRVs may be awarded by FDA on approval of a new medicine for a rare pediatric disease, providing it is the first approval for that medicine
•To be eligible for a pPRV, the drug must have been granted Rare Pediatric Disease Designation (RPDD) prior to filing for approval – ATL1102 has been granted RPDD
•A PRV allows the holder to accelerate FDA review of any new drug application from ~12 months to ~6 months. For a high-value product, this acceleration is very valuable. The holder does not have to use the voucher on the drug for which it was originally granted
•PRVs can be freely traded between companies. The current market price is in excess of US$ 100M

PRV info taken from company presentation.

Expand

If this trial is successful, we may not need to worry about funds ..even though our own funds would be handy...

I would be surprised if a Pharma is not waiting with a cheque book, when the results are due along with the Tox data...

Question then would be ...what is the number on the Cheque..
Imo...

Last edited by arjay: 04/09/23

ANP Price at posting: 6.1¢ Sentiment: Buy Disclosure: Held
11 Upvote

2 Great analysis

Reply

Top Stories

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 889 more messages in this thread...

First 2667 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change -0.003(3.53%)		Mkt cap ! $85.01M

Open	High	Low	Value	Volume
8.5¢	8.6¢	8.2¢	$103.7K	1.237M

Buyers (Bids)

No.	Vol.	Price($)
3	204084	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.5¢	280000	3

View Market Depth

No.	Vol.	Price($)
3	204084	0.082
3	287000	0.081
8	672686	0.080
6	413817	0.079
6	689399	0.078

Price($)	Vol.	No.
0.085	280000	3
0.086	96543	1
0.088	27962	1
0.089	200000	1
0.090	604764	4

Last trade - 16.10pm 13/11/2024 (20 minute delay)

PER (ASX) Chart

If this trial is successful, we may not need to worry about...

Overland drilling proves promising for Australian Rare Earths' uranium hopes

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

If this trial is successful, we may not need to worry about...

Top Stories

Overland drilling proves promising for Australian Rare Earths' uranium hopes

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News